Pure Global
NCT05154669

Integrating Financial Coaching and Smoking Cessation Coaching

Integrating Financial Coaching and Smoking Cessation Coaching for People With Low Income Who Smoke: a Randomized Controlled Trial
NYU Langone Health·Phase 3·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Smoking
Drug/Device/Intervention
Financial counseling
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
NYU Langone Health
Location
New York, United States of America
Timeline & enrollment
Phase
Phase 3
Start date
Dec 06, 2022
End date
Jan 01, 2027
Enrollment
900 participants
Primary outcome

Effectiveness of the integrated intervention to standard cessation counseling on long-term abstinence (salivary cotinine),Effectiveness of the integrated intervention to standard cessation counseling on long-term abstinence (CO concentration)

Summary

This study conduct a two-arm, parallel-group randomized controlled trial. The study will
 recruit and randomize 900 smokers (n=450 per arm) to either: (1) Control: Standard Smoking
 Cessation Counseling or (2) Intervention: Integrated Financial-Smoking Cessation Counseling.

ICD-10 classifications
Tobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco : harmful useDrug use
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05154669
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05154669 through Pure Global AI's free database. This Phase 3 trial is sponsored by NYU Langone Health and is currently Recruiting. The study focuses on Smoking. Target enrollment is 900 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.